| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.03 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.079 | 0.04 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.07 | 0.04 |